Products 1005342-46-0

CAS 1005342-46-0 appears in our catalog under these names: LCL 161, LCL161, LCL161/ 99.72% (existing batch purity), LCL161 98%, (2S)-N-[(1S)-1-Cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-propanamide, 98%, 98%. Offered by: TRC, GLPBio, TargetMol, Biosynth, Ambeed. Available pack sizes: 1g, 10mg, 100mg, 5mg, 10mM (in 1ml dmso), 50mg, 2mg, 25mg.

Structural formula: {0} (CAS {1})

LCL161 is a small molecule inhibitor of IAPs that has potent antitumour activity in a range of solid tumours. In HCC, response to LCL161 therapy has shown to be mediated by Bcl-2 expression. It has a role as an antineoplastic agent and an apoptosis inducer. It is a member of 1,3-thiazoles, a N-acylpyrrolidine, an aromatic ketone, a member of monofluorobenzenes and a L-alanine derivative.

Source: ChEBI

Identity
Molecular formulaC26H33FN4O3S
Molecular weight500.6 g/mol
IUPAC name(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide
InChIKeyUFPFGVNKHCLJJO-SSKFGXFMSA-N
SMILESC[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC

Computed by PubChem (NCBI)